CPT-6281

N/A

Report date: 2025/07/07 20:00:09
NME

Base Information

Drug NameCPT-6281
Drug Alias NameCPT-6281CT-01
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)Small molecules > Molecular Glue
Mechanisms of ActionEukaryotic peptide chain release factor GTP-binding subunit ERF3A degradersSal-like protein 4 degradersSerine/threonine-protein kinase Nek7 degraders
TargetsEukaryotic peptide chain release factor GTP-binding subunit ERF3ASal-like protein 4Serine/threonine-protein kinase Nek7
Therapy Area/IndicationsCarcinoma, HepatocellularNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCaptor Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesCaptor Therapeutics SA
Inactive CompaniesN/A
Active IndicationsCarcinoma, HepatocellularNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A